SNODGRASS H. RALPH 4
4 · VistaGen Therapeutics, Inc. · Filed Jul 2, 2021
Insider Transaction Report
Form 4
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Stock
2021-06-30$1.95/sh+3,391$6,601→ 91,115 total
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).